Svetlana V. Khokhlova

Moscow, MOW 117997, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Circulating Tumor DNA And Its Potential Applications for Assessing Effectiveness of Neoadjuvant Drug Therapy in the Breast Cancer Patients.

Circulating Tumor DNA And Its Potential Applications for Assessing Effectiveness of Neoadjuvant Drug Therapy in the Breast Cancer Patients.

Journal: Biochemistry. Biokhimiia

Published: December 07, 2025

The Role of Sphingolipid Metabolism in Pregnancy-Associated Breast Cancer After Chemotherapy.

The Role of Sphingolipid Metabolism in Pregnancy-Associated Breast Cancer After Chemotherapy.

Journal: Biomedicines

Published: November 14, 2024

Prevalence of homologous recombination deficiency among women with newly diagnosed ovarian, primary peritoneal, and/or fallopian tube cancer: the international HALO study.

Prevalence of homologous recombination deficiency among women with newly diagnosed ovarian, primary peritoneal, and/or fallopian tube cancer: the international HALO study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: October 28, 2024

Molecular Subgroups of HRD Positive Ovarian Cancer and Their Prognostic Significance.

Molecular Subgroups of HRD Positive Ovarian Cancer and Their Prognostic Significance.

Journal: International journal of molecular sciences

Published: October 13, 2024

The association of rs25487 of the XRCC1 gene and rs13181 of the ERCC2 gene polymorphisms with the ovarian cancer risk.

The association of rs25487 of the XRCC1 gene and rs13181 of the ERCC2 gene polymorphisms with the ovarian cancer risk.

Journal: Biomolecules & biomedicine

Published: September 21, 2024

Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients.

Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients.

Journal: International journal of molecular sciences

Published: October 19, 2023

HRD Testing of Ovarian Cancer in Routine Practice: What Are We Dealing With?

HRD Testing of Ovarian Cancer in Routine Practice: What Are We Dealing With?

Journal: International journal of molecular sciences

Published: May 24, 2023

Modern instrumental methods for early diagnosis of dental caries

Modern instrumental methods for early diagnosis of dental caries

Journal: Stomatologiia

Published: February 21, 2022

Association between Molecular Genetic Markers of DNA Repair and Cell Cycle Control Genes and Response to Platinum-Based Chemotherapy in Ovarian Cancer Patients.

Association between Molecular Genetic Markers of DNA Repair and Cell Cycle Control Genes and Response to Platinum-Based Chemotherapy in Ovarian Cancer Patients.

Journal: Bulletin of experimental biology and medicine

Published: January 11, 2021

Association of Molecular Genetic Markers of TP53, MDM2, and CDKN1A Genes with Progression-Free Survival of Patients with Ovarian Cancer after Platinum-Based Chemotherapy.

Association of Molecular Genetic Markers of TP53, MDM2, and CDKN1A Genes with Progression-Free Survival of Patients with Ovarian Cancer after Platinum-Based Chemotherapy.

Journal: Bulletin of experimental biology and medicine

Published: December 30, 2019

Chemoradiotherapy for locally advanced cervical cancer

Chemoradiotherapy for locally advanced cervical cancer

Journal: Voprosy onkologii

Published: July 19, 2014

Which patients with ovarian cancer shows the combination of trabectedin with pegylated liposomal doxorubicin

Which patients with ovarian cancer shows the combination of trabectedin with pegylated liposomal doxorubicin

Journal: Vestnik Rossiiskoi akademii meditsinskikh nauk

Published: January 01, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026